APA (7th ed.) Citation

Y, S., R, X., H, S., L, Y., H, W., & B, L. (2025). Human epidermal growth factor 2 (HER2) amplification in uterine serous carcinoma: An analysis of prognosis and immune microenvironment. Virchows Archiv : an international journal of pathology, 486(4), 707. https://doi.org/10.1007/s00428-024-03874-w

Chicago Style (17th ed.) Citation

Y, Shao, Xu R, Shi H, Ye L, Wang H, and Lu B. "Human Epidermal Growth Factor 2 (HER2) Amplification in Uterine Serous Carcinoma: An Analysis of Prognosis and Immune Microenvironment." Virchows Archiv : An International Journal of Pathology 486, no. 4 (2025): 707. https://doi.org/10.1007/s00428-024-03874-w.

MLA (9th ed.) Citation

Y, Shao, et al. "Human Epidermal Growth Factor 2 (HER2) Amplification in Uterine Serous Carcinoma: An Analysis of Prognosis and Immune Microenvironment." Virchows Archiv : An International Journal of Pathology, vol. 486, no. 4, 2025, p. 707, https://doi.org/10.1007/s00428-024-03874-w.